speb/financial-data huggingface dataset:
HEADSUP.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 0.00
HEADSUP.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
HEADSUP.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
HEADSUP.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
HEADSUP.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
HEADSUP.NS balance_sheet (annual, 2025-03-31) — Working Capital: 141958000.00
HEADSUP.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 141958000.00
HEADSUP.NS income_statement (annual, 2025-03-31) — Write Off: 0.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 4474000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 115024000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 22077273.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 1.32
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 88867000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 0.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 0.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 22077273.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.32
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 29142000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — EBIT: 29142000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — EBITDA: 29142000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 26157000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 0.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 0.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Net Income: 29142000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 29142000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 29142000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 0.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 29142000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 29142000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 29142000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: 0.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 0.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 29142000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 29142000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Operating Income: 21683000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 115024000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 7460000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 3798000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 29142000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 88867000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 0.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 93341000.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
HEADSUP.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 410000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 29588000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 49208000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 105175000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 11349000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 22345714.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 0.35
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 220826000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 10486000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 73156000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 220826000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 190597000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 0.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 29006000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 253421000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 77383000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 0.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 0.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 22345714.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.35
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 7821000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — EBIT: 10463000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — EBITDA: 10463000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1525000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 582000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 0.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 190597000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Investment Properties: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 11349000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 5981000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Net Income: 7821000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 7821000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 7821000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 0.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 7821000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 7821000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 7821000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: 0.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 1525000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 190597000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 0.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 10463000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 7821000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Operating Income: 172000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 29588000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 22082609.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 6822000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: -30229000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 7666000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 10291000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 2000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 1525000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 75090000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 62670000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Payables: 49208000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 10463000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 29006000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 22082609.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 190597000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 190597000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 2642000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 273961000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 190597000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 190597000.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 29416000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 83364000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 20540000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 5981000.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 0.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
HEADSUP.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
HEADSUP.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 176038000.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 6093000.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 21760714.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Basic EPS: -0.28
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 0.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 0.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 0.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 21760714.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.28
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -6093000.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — EBIT: -6093000.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — EBITDA: -6093000.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 0.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 0.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 0.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Net Income: -6093000.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -6093000.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -6093000.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -6093000.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -6093000.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -6093000.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: 0.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 0.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -6093000.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Normalized Income: -6093000.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Operating Income: -6093000.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 5765000.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Pretax Income: -6093000.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 0.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 0.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 0.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 6093000.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
HEADSUP.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
HEADSUP.NS income_statement (annual, 2026-03-31) — +Operating Expense: 12297000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 1291000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — +Total Revenue: 172634000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 28022000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 259484000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 259484000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 178397000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 178397000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 77427000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 77427000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 22082609.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 22104965.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Basic EPS: -0.01
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Basic EPS: -1.41
HEADSUP.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 22875000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 220826000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 220826000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 10328000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 10328000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 10328000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 10328000.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -91418000.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -96775000.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 7614000.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Change In Payable: 258067000.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -92664000.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -9210000.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -12547000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Common Stock: 220826000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 220826000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 153309000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 153309000.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 285000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 175712000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 57839000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Current Assets: 364234000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 364234000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Current Debt: 0.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 0.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 0.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 0.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 297600000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 297600000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 5981000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 5981000.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Depreciation: 44000.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 44000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 44000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 43000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 44000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 43000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 22082609.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 22104965.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Diluted EPS: -0.01
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: -1.41
HEADSUP.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: -326000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -31168000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — EBIT: 2376000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — EBIT: -31108000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — EBITDA: 2420000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — EBITDA: -31065000.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — End Cash Position: 10328000.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -3055000.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -9492000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Gross Profit: -3078000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Gross Profit: -29817000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Interest Expense: 0.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 0.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 0.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 0.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 0.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Inventory: 91418000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 91418000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 153309000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 153309000.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: 0.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 77427000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 77427000.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 285000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 0.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 0.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 0.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 0.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 285000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Net Income: -326000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Net Income: -31168000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: -326000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -31168000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: -326000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -31168000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -326000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -31168000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -326000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -31168000.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 2376000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: -326000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -31168000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Net Interest Income: 0.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: 0.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 0.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -3340000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: 0.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 0.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Net PPE: 1483000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 1483000.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: 0.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -3340000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 153309000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 153309000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 0.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 0.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 0.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 0.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 2420000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -31065000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Normalized Income: -326000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Normalized Income: -31168000.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: -9492000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Operating Income: -15375000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Operating Income: -31108000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Operating Revenue: 172634000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 28022000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 22082609.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 22082609.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 84091000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 84091000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 10782000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 10782000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: -67517000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: -67517000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 7765000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 7765000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 17751000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 10045000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 452000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Payables: 259484000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Payables: 259484000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Pretax Income: 2376000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Pretax Income: -31108000.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 0.00
HEADSUP.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: 0.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 175712000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 57839000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 44000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 43000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Share Issued: 22082609.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 22082609.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 153309000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 153309000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 153309000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 153309000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Tax Provision: 2702000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 60000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
HEADSUP.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -2702000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Total Assets: 450909000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 450909000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 153309000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 153309000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Total Debt: 0.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 0.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 153309000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 153309000.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Total Expenses: 188009000.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 59130000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 297600000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 297600000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 86675000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 86675000.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 0.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 0.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 0.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
HEADSUP.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
HEADSUP.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
HEADSUP.NS balance_sheet (annual, 2026-03-31) — Working Capital: 66634000.00
HEADSUP.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 66634000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — +Operating Expense: 971912000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — +Total Revenue: 6297996000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 330621000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 211982000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -173947000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 1400044000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -8384000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Amortization: 2238000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 2238000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 8002456000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 31810500.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Basic EPS: 197.04
HEALTHX.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 120418000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 282912000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -47301000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 18534000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 318105000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 130055000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 2121432000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 15996000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 114059000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Change In Inventory: -363522000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Change In Other Current Assets: -77081000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: 54357000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Change In Payable: -37115000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Change In Receivables: -95750000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: -527668000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Changes In Cash: 9637000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Common Stock: 318105000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 8265021000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 4241000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 5852647000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Current Assets: 3587508000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 3637000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Current Debt: 0.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 3637000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 579725000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Depreciation: 39324000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 41562000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 41562000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 39324000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 31810500.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Diluted EPS: 197.04
HEALTHX.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 6268054000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Dividends Received Cfi: 1935000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — EBIT: 11111036000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — EBITDA: 11152598000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — End Cash Position: 130055000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1339798000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: -114222000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 1122989000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: -2118853000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -4831865000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of Business: -6742973000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: -6000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 38156000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Goodwill: 361434000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 362589000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 220366000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 575844000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Gross Profit: 445349000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Interest Expense: 16198000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 16198000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Interest Income: 25617000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 25617000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -16362000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Interest Received Cfi: 4125000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Inventory: 1135335000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 8265021000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: 2195411000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Investment Properties: 0.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 8002456000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 4838498000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 23422000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 14897000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 0.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 14897000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 4838498000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Long Term Provisions: 10071000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 151000000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Minority Interest: 2677267000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Minority Interests: -2383068000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Net Income: 6268054000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 6268054000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 8651122000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 6268054000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 6268054000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 11094838000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 8651122000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Net Interest Income: -7779000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 2236198000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -97860000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -97860000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -7779000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Net PPE: 575844000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -46847000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: -97860000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 7902432000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 389000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 1136803000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 20631000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Normalized EBITDA: -500283000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Normalized Income: -2818198109.54
HEALTHX.NS cash_flow (annual, 2022-03-31) — Operating Cash Flow: -2071552000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Operating Income: -526563000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Operating Revenue: 6297996000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 31810500.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: 50000000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 1155000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 5440000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Other Investments: 1201271000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Other Non Cash Items: -43382000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: 249178000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 10344000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 28160000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 384462000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Other Payable: 41296000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Other Properties: 571603000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 96456000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 1991377000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Other Special Charges: -11590380000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Payables: 566225000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Pension And Employee Benefit Expense: 7700000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 22303000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Pretax Income: 11094838000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Provisionand Write Offof Assets: 0.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment: -12400870000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Purchase Of PPE: -47301000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 6906000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 5852647000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 41562000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 14152000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 14152000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Research And Development: 0.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 5226558000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Sale Of Investment: 14637068000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 454000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 52714000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 90870000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Share Issued: 31810500.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Special Income Charges: 11589580000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Stockholders Equity: 8265021000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Tangible Book Value: 7902432000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 2566628890.46
HEALTHX.NS income_statement (annual, 2022-03-31) — Tax Provision: 2443716000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.22
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 22303000.00
HEALTHX.NS cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -1128790000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Total Assets: 12777964000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Total Capitalization: 8265021000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Total Debt: 18534000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 10942288000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Total Expenses: 6824559000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 1835676000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 9190456000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 1255951000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 17198000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 194308000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Total Unusual Items: 11652881000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 11652881000.00
HEALTHX.NS balance_sheet (annual, 2022-03-31) — Working Capital: 3007783000.00
HEALTHX.NS income_statement (annual, 2022-03-31) — Write Off: 800000.00
HEALTHX.NS income_statement (annual, 2023-03-31) — +Operating Expense: 1225898000.00
HEALTHX.NS income_statement (annual, 2023-03-31) — +Total Revenue: 10381881000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 569695000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 350827000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -241228000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 1400044000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -38390000.00
HEALTHX.NS income_statement (annual, 2023-03-31) — Amortization: 491000.00
HEALTHX.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 491000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 24939000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 1310737000.00
HEALTHX.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 31810500.00
HEALTHX.NS income_statement (annual, 2023-03-31) — Basic EPS: -22.70
HEALTHX.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 130055000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 259967000.00
HEALTHX.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -194873000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 93252000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 318105000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 317214000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 2076357000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 243026000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 74188000.00
HEALTHX.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -672983000.00
HEALTHX.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -202923000.00
HEALTHX.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 94272000.00
HEALTHX.NS cash_flow (annual, 2023-03-31) — Change In Payable: 239438000.00
HEALTHX.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -233481000.00
HEALTHX.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -776591000.00
HEALTHX.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 187159000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Common Stock: 318105000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 7534004000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 37615000.00
HEALTHX.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 9670342000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Current Assets: 4862074000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 12396000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 12396000.00
HEALTHX.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 891784000.00
HEALTHX.NS cash_flow (annual, 2023-03-31) — Depreciation: 81484000.00
HEALTHX.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 81975000.00
HEALTHX.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 81975000.00